# NICO Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nico

- Industry: Medical Devices & Equipment
- Headquarters: Indianapolis, US
- Website: www.niconeuro.com/
- Total disclosed funding: $10M
- Latest round: Series C (Jul 20, 2009)
- Investors on record: 4

## About

Based in the US, NICO Corporation operates in the field of minimally invasive neurosurgery, focusing on innovative technologies that enhance surgical procedures and improve patient outcomes.NICO Corporation, founded in 2007 and headquartered in Indianapolis, US, specializes in advanced surgical technologies. The company has made a total of 9 deals, with its most recent deal occurring on September 20, 2024, leading to its acquisition by Stryker Corporation from several investors including RC Capital. The CEO is Jim Pearson.NICO Corporation specializes in advanced technologies aimed at transforming minimally invasive neurosurgery. Its core product offerings include the NICO Myriad and BrainPath systems, which integrate imaging and intervention to enhance surgical precision and patient outcomes. The NICO Myriad SPECTRA features a hand-held design with a blue excitation light that assists surgeons in identifying critical tissues during procedures. These innovations address complex medical challenges, particularly for patients experiencing conditions such as Intracerebral Hemorrhage (ICH). NICO's products are utilized by neurosurgeons and healthcare providers across international markets, including North America, Europe, and select regions in Asia.NICO Corporation generates revenue through the sale of its proprietary surgical technologies, including the NICO Myriad and BrainPath systems, primarily to hospitals and surgical centers. The transaction structure typically involves direct sales to healthcare providers. Revenue is driven by individual product sales, emphasizing long-term relationships with clients through continued support and education on the technologies. The flagship products aim to facilitate improved surgical outcomes, creating a compelling value proposition for healthcare institutions. Specific pricing details for these technologies are not publicly available; however, they are positioned as premium solutions within the market.Following its acquisition by Stryker Corporation on September 20, 2024, NICO Corporation is expected to enhance Stryker's portfolio in minimally invasive technologies for brain tumor removal and stroke care. The integration aims to support the expansion of NICO's existing products into new markets, leveraging Stryker's distribution channels. The recent acquisition will likely provide the necessary resources to bolster product development and market penetration strategies in targeted regions.

## Funding rounds

- Series C, Jul 20, 2009, $10M — RC Capital, CHV Capital, Twilight Venture Partners, The HALO Group

## Investors

- RC Capital (https://capitalatlas.ai/funds/rc-capital) — Series C
- CHV Capital (https://capitalatlas.ai/funds/chv-capital) — Series C
- Twilight Venture Partners (https://capitalatlas.ai/funds/twilight-venture-partners) — Series C
- The HALO Group — Series C